{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:08:05Z","timestamp":1790737685617,"version":"4.1.0"},"reference-count":89,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Pikeville, Kentucky College of Osteopathic Medicine, KY, USA","award":["Start-UP"],"award-info":[{"award-number":["Start-UP"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers and is the third highest among cancer related deaths. Despite modest success with therapy such as gemcitabine, pancreatic cancer incidence remains virtually unchanged in the past 25 years. Among the several driver mutations for PDAC, Kras mutation contributes a central role for its development, progression and therapeutic resistance. In addition, inflammation is implicated in the development of most human cancer, including pancreatic cancer. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB) is recognized as a key mediator of inflammation and has been frequently observed to be upregulated in PDAC. Several lines of evidence suggest that NF-\u03baB pathways play a crucial role in PDAC development, progression and resistance. In this review, we focused on emphasizing the recent advancements in the involvement of NF-\u03baB in PADC\u2019s progression and resistance. We also highlighted the interaction of NF-\u03baB with other signaling pathways. Lastly, we also aim to discuss how NF-\u03baB could be an excellent target for PDAC prevention or therapy. This review could provide insight into the development of novel therapeutic strategies by considering NF-\u03baB as a target to prevent or treat PDAC.<\/jats:p>","DOI":"10.3390\/ijms19123890","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T12:22:00Z","timestamp":1544012520000},"page":"3890","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Advancement of NF-\u03baB Signaling Pathway: A Novel Target in Pancreatic Cancer"],"prefix":"10.3390","volume":"19","author":[{"given":"Kartick C.","family":"Pramanik","sequence":"first","affiliation":[{"name":"Department of Basic Sciences, Kentucky College of Osteopathic Medicine, University of Pikeville, Pikeville, KY 41501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4068-7375","authenticated-orcid":false,"given":"Monish Ram","family":"Makena","sequence":"additional","affiliation":[{"name":"Department of Physiology, The Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuntal","family":"Bhowmick","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ 08103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ 08103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the united states","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Saad, A.M., Turk, T., Al-Husseini, M.J., and Abdel-Rahman, O. (2018). Trends in pancreatic adenocarcinoma incidence and mortality in the united states in the last four decades; a seer-based study. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4610-4"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.3748\/wjg.v22.i44.9694","article-title":"Epidemiology of pancreatic cancer","volume":"22","author":"Ilic","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","article-title":"Age and cancer risk: A potentially modifiable relationship","volume":"46","author":"White","year":"2014","journal-title":"Am. J. Prev. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00423-007-0266-2","article-title":"Tobacco and the risk of pancreatic cancer: A review and meta-analysis","volume":"393","author":"Iodice","year":"2008","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archinternmed.2010.63","article-title":"Anthropometric measures, body mass index, and pancreatic cancer: A pooled analysis from the pancreatic cancer cohort consortium (panscan)","volume":"170","author":"Arslan","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/annonc\/mdu276","article-title":"Diabetes, antidiabetic medications, and pancreatic cancer risk: An analysis from the international pancreatic cancer case-control consortium","volume":"25","author":"Bosetti","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2015.09.020","article-title":"Subtyping pancreatic cancer","volume":"28","author":"Biankin","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_12","first-page":"123","article-title":"Pancreatic cancer: Current research and future directions","volume":"1865","author":"Falasca","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic developments in pancreatic cancer: Current and future perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: A blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: Coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0092-8674(00)81409-9","article-title":"Cotranslational biogenesis of NF-\u03baB p50 by the 26s proteasome","volume":"92","author":"Lin","year":"1998","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.it.2008.07.003","article-title":"New insights into NF-\u03baB regulation and function","volume":"29","author":"Sun","year":"2008","journal-title":"Trends Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5306\/wjco.v2.i5.195","article-title":"Genetically-engineered mouse models for pancreatic cancer: Advances and current limitations","volume":"2","author":"Ijichi","year":"2011","journal-title":"World J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"41421","DOI":"10.18632\/oncotarget.9404","article-title":"Apigenin inhibits NF-\u03baB and snail signaling, emt and metastasis in human hepatocellular carcinoma","volume":"7","author":"Qin","year":"2016","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","article-title":"The ikk complex, a central regulator of NF-\u03baB activation","volume":"2","author":"Israel","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1097-2765(01)00187-3","article-title":"NF-\u03baB-inducing kinase regulates the processing of NF-\u03baB2 p100","volume":"7","author":"Xiao","year":"2001","journal-title":"Mol. Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1126\/science.1062677","article-title":"Activation by ikkalpha of a second, evolutionary conserved, NF-\u03baB signaling pathway","volume":"293","author":"Senftleben","year":"2001","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/onc.2010.566","article-title":"NF-\u03baB addiction and its role in cancer: \u2018One size does not fit all\u2019","volume":"30","author":"Chaturvedi","year":"2011","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Park, M.H., and Hong, J.T. (2016). Roles of NF-\u03baB in cancer and inflammatory diseases and their therapeutic approaches. Cells, 5.","DOI":"10.3390\/cells5020015"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","article-title":"Dangerous liaisons: Stat3 and NF-\u03baB collaboration and crosstalk in cancer","volume":"21","author":"Grivennikov","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2006-07-025809","article-title":"Aberrant NF-\u03baB signaling in lymphoma: Mechanisms, consequences, and therapeutic implications","volume":"109","author":"Jost","year":"2007","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fonc.2013.00120","article-title":"Targeting nuclear factor-kappa B to overcome resistance to chemotherapy","volume":"3","author":"Godwin","year":"2013","journal-title":"Front. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/MCB.19.9.5892","article-title":"Suppression of ras-induced apoptosis by the rac gtpase","volume":"19","author":"Joneson","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"36671","DOI":"10.1074\/jbc.M203213200","article-title":"C-myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor \u03baB transactivation","volume":"277","author":"You","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-065X.2012.01095.x","article-title":"Regulation of cell death and autophagy by ikk and NF-\u03baB: Critical mechanisms in immune function and cancer","volume":"246","author":"Baldwin","year":"2012","journal-title":"Immunol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1128\/MCB.01396-08","article-title":"P65\/rela modulates becn1 transcription and autophagy","volume":"29","author":"Copetti","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"849541","DOI":"10.1155\/2012\/849541","article-title":"Context-dependent regulation of autophagy by ikk-NF-\u03baB signaling: Impact on the aging process","volume":"2012","author":"Salminen","year":"2012","journal-title":"Int. J. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4161\/cbt.8.16.8961","article-title":"Constitutive non-canonical nfkappab signaling in pancreatic cancer cells","volume":"8","author":"Wharry","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.semcancer.2016.08.005","article-title":"NF-\u03baB dysregulation in multiple myeloma","volume":"39","author":"Matthews","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2741\/3782","article-title":"NF-\u03baB in lung cancer, a carcinogenesis mediator and a prevention and therapy target","volume":"16","author":"Chen","year":"2011","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1756-9966-27-53","article-title":"NF-\u03baB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues","volume":"27","author":"Meteoglu","year":"2008","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10969","DOI":"10.18632\/oncotarget.2624","article-title":"Critical role of NF-\u03baB in pancreatic cancer","volume":"5","author":"Prabhu","year":"2014","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MPA.0000000000000039","article-title":"Zerumbone inhibits angiogenesis by blocking NF-\u03baB activity in pancreatic cancer","volume":"43","author":"Shamoto","year":"2014","journal-title":"Pancreas"},{"key":"ref_42","first-page":"725","article-title":"Constitutive NF-\u03baB activity regulates the expression of vegf and il-8 and tumor angiogenesis of human glioblastoma","volume":"23","author":"Xie","year":"2010","journal-title":"Oncol. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Soubannier, V., and Stifani, S. (2017). NF-\u03baB signalling in glioblastoma. Biomedicines, 5.","DOI":"10.3390\/biomedicines5020029"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40880-017-0206-7","article-title":"Cancer metastasis: Issues and challenges","volume":"36","author":"Qian","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3892\/or.2016.5044","article-title":"Curcumin inhibits h2o2-induced invasion and migration of human pancreatic cancer via suppression of the erk\/NF-\u03baB pathway","volume":"36","author":"Cao","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200421358","article-title":"NF-\u03baB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression","volume":"114","author":"Huber","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kumar, M., Allison, D.F., Baranova, N.N., Wamsley, J.J., Katz, A.J., Bekiranov, S., Jones, D.R., and Mayo, M.W. (2013). NF-\u03baB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068597"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Pires, B.R., Mencalha, A.L., Ferreira, G.M., de Souza, W.F., Morgado-Diaz, J.A., Maia, A.M., Correa, S., and Abdelhay, E.S. (2017). NF-\u03baB is involved in the regulation of emt genes in breast cancer cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169622"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1158\/0008-5472.CAN-11-3123","article-title":"Epithelial-mesenchymal transition induced by tnf-\u03b1 requires NF-\u03baB-mediated transcriptional upregulation of twist1","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/febs.13578","article-title":"NF-\u03baB and hif crosstalk in immune responses","volume":"283","author":"Bandarra","year":"2016","journal-title":"FEBS J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/MD.0000000000004765","article-title":"Cancer stem cell signaling pathways","volume":"95","author":"Matsui","year":"2016","journal-title":"Medicine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/stem.1394","article-title":"Epigenetic regulation of sox9 by the NF-\u03baB signaling pathway in pancreatic cancer stem cells","volume":"31","author":"Sun","year":"2013","journal-title":"Stem Cells"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/0008-5472.CAN-16-1898","article-title":"Kras\/NF-\u03baB\/yy1\/mir-489 signaling axis controls pancreatic cancer metastasis","volume":"77","author":"Yuan","year":"2017","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2011.12.006","article-title":"Krasg12d-induced ikk2\/\u03b2\/NF-\u03baB activation by il-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma","volume":"21","author":"Ling","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1158\/2159-8290.CD-12-0541","article-title":"Gsk-3\u03b1 promotes oncogenic kras function in pancreatic cancer via tak1-tab stabilization and regulation of noncanonical NF-\u03baB","volume":"3","author":"Bang","year":"2013","journal-title":"Cancer Discov."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1172\/JCI45797","article-title":"Crosstalk between the canonical NF-\u03baB and notch signaling pathways inhibits ppargamma expression and promotes pancreatic cancer progression in mice","volume":"121","author":"Maniati","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"33571","DOI":"10.18632\/oncotarget.9654","article-title":"Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug th-302","volume":"7","author":"Lohse","year":"2016","journal-title":"Oncotarget"},{"key":"ref_58","first-page":"91","article-title":"The impact of hypoxia in pancreatic cancer invasion and metastasis","volume":"2","author":"Yuen","year":"2014","journal-title":"Hypoxia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3892\/or.2014.3022","article-title":"Effects of the hif-1\u03b1 and NF-\u03baB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells","volume":"31","author":"Cheng","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_60","first-page":"346","article-title":"Function of nuclear factor \u03baB in pancreatic cancer metastasis","volume":"9","author":"Fujioka","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2016.08.023","article-title":"Gemcitabine treatment promotes pancreatic cancer stemness through the nox\/ros\/NF-\u03baB\/stat3 signaling cascade","volume":"382","author":"Zhang","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Amrutkar, M., and Gladhaug, I.P. (2017). Pancreatic cancer chemoresistance to gemcitabine. Cancers, 9.","DOI":"10.3390\/cancers9110157"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/onc.2012.179","article-title":"The muc4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the concentrative nucleoside transporter family","volume":"32","author":"Skrypek","year":"2013","journal-title":"Oncogene"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.omtn.2018.01.004","article-title":"Mir-1266 contributes to pancreatic cancer progression and chemoresistance by the stat3 and NF-\u03baB signaling pathways","volume":"11","author":"Zhang","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/mc.22503","article-title":"Downregulation of stat3\/NF-\u03baB potentiates gemcitabine activity in pancreatic cancer cells","volume":"56","author":"Gong","year":"2017","journal-title":"Mol. Carcinog."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1158\/1078-0432.CCR-08-1539","article-title":"Nuclear factor-\u03baB p65\/rela silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells","volume":"14","author":"Pan","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.7150\/thno.23259","article-title":"Oncogenic trim31 confers gemcitabine resistance in pancreatic cancer via activating the NF-\u03baB signaling pathway","volume":"8","author":"Yu","year":"2018","journal-title":"Theranostics"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/cgt.2016.71","article-title":"Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes","volume":"23","author":"Mezencev","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/jnci\/djr243","article-title":"Modulation of pancreatic cancer chemoresistance by inhibition of tak1","volume":"103","author":"Melisi","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_70","first-page":"119","article-title":"The nuclear factor-\u03baB rela transcription factor is constitutively activated in human pancreatic adenocarcinoma cells","volume":"5","author":"Wang","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_71","first-page":"946","article-title":"Epigallocatechin-3-gallate prevents tnf-\u03b1-induced NF-\u03baB activation thereby upregulating abca1 via the nrf2\/keap1 pathway in macrophage foam cells","volume":"29","author":"Jiang","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"G275","DOI":"10.1152\/ajpgi.00344.2009","article-title":"TGF-\u03b2 downregulates pten via activation of NF-\u03baB in pancreatic cancer cells","volume":"298","author":"Chow","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"21091","DOI":"10.1074\/jbc.M500754200","article-title":"Coactivators and corepressors of NF-\u03baB in I\u03baB\u03b1 gene promoter","volume":"280","author":"Gao","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1023\/B:PHAM.0000022413.43212.cf","article-title":"Modulatory properties of various natural chemopreventive agents on the activation of NF-\u03baB signaling pathway","volume":"21","author":"Jeong","year":"2004","journal-title":"Pharm. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bcp.2008.07.017","article-title":"Activation of nrf2-antioxidant signaling attenuates NF\u03baB-inflammatory response and elicits apoptosis","volume":"76","author":"Li","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15384101.2015.1127468","article-title":"Inflammatory stimuli promote growth and invasion of pancreatic cancer cells through NF-\u03baB pathway dependent repression of pp2ac","volume":"15","author":"Tao","year":"2016","journal-title":"Cell Cycle"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MPA.0b013e31815b3207","article-title":"The role of nuclear factor kappab in pancreatic cancer and the clinical applications of targeted therapy","volume":"36","author":"Holcomb","year":"2008","journal-title":"Pancreas"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of i\u03baB kinase-\u03b2","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1158\/1535-7163.1421.3.11","article-title":"Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines","volume":"3","author":"Ali","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1158\/1535-7163.MCT-04-0215","article-title":"Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-\u03baB pathway in pancreatic carcinoma cells","volume":"4","author":"Nakshatri","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/cncr.21075","article-title":"Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin","volume":"103","author":"Sclabas","year":"2005","journal-title":"Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Bimonte, S., Barbieri, A., Leongito, M., Piccirillo, M., Giudice, A., Pivonello, C., de Angelis, C., Granata, V., Palaia, R., and Izzo, F. (2016). Curcumin anticancer studies in pancreatic cancer. Nutrients, 8.","DOI":"10.3390\/nu8070433"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2012.10.020","article-title":"Pancreatic cancer chemoprevention by phytochemicals","volume":"334","author":"Boreddy","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/nutrit\/nuu064","article-title":"Curcumin and cancer: Barriers to obtaining a health claim","volume":"73","author":"Devassy","year":"2015","journal-title":"Nutr. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0027-5107(01)00183-X","article-title":"Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of cox-2 and inos through suppression of NF-\u03baB activation","volume":"480","author":"Surh","year":"2001","journal-title":"Mutat. Res."},{"key":"ref_86","first-page":"645","article-title":"Potential anticancer properties and mechanisms of action of curcumin","volume":"35","author":"Vallianou","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2002-05-1320","article-title":"Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-\u03baB and I\u03baB\u03b1 kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis","volume":"101","author":"Bharti","year":"2003","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1158\/0008-5472.CAN-06-4257","article-title":"Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-\u03baB-regulated gene products","volume":"67","author":"Kunnumakkara","year":"2007","journal-title":"Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","article-title":"Phase ii trial of curcumin in patients with advanced pancreatic cancer","volume":"14","author":"Dhillon","year":"2008","journal-title":"Clin. Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/12\/3890\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:31:18Z","timestamp":1760196678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/12\/3890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":89,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["ijms19123890"],"URL":"https:\/\/doi.org\/10.3390\/ijms19123890","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]}}}